Switzerland · Venture startup

Who invested in T3 Pharmaceuticals

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

Undisclosedraised across 1 round since 2023, from 1 source

Latest round
VentureApr 2023
Investors
2
See who backed them

The rounds

  1. Apr 2023
    VentureAmount undisclosed

    Source recorded

Founders and team

From T3 Pharmaceuticals's own website: 2 on the team.

  • Dr. Simon J. IttigChief Executive Officer
  • Dr. Christoph A. KasperChief Scientific Officer

Everyone who backed them

InnosuisseGovernment1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about T3 Pharmaceuticals

Who invested in T3 Pharmaceuticals?

T3 Pharmaceuticals's investors include Innosuisse and Boehringer Ingelheim Venture Fund.

How much has T3 Pharmaceuticals raised?

T3 Pharmaceuticals has raised 1 round since 2023, none with a disclosed amount.

When did T3 Pharmaceuticals last raise?

T3 Pharmaceuticals's most recent round was a Venture in Apr 2023.

Who backed T3 Pharmaceuticals first?

T3 Pharmaceuticals's first round on record, in Apr 2023, was backed by Innosuisse and Boehringer Ingelheim Venture Fund.

What stage is T3 Pharmaceuticals at?

T3 Pharmaceuticals's latest named round is a Venture, in Apr 2023.

Where is T3 Pharmaceuticals based?

T3 Pharmaceuticals is based in Switzerland.

Companies like T3 Pharmaceuticals

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.